Inhibitors Inducers
Found 5 free book(s)
HIGHLIGHTS OF PRESCRIBING INFORMATION o For patients …
docs.boehringer-ingelheim.com5.5 Effect of P-gp Inducers and Inhibitors on Dabigatran Exposure 5.6 Increased Risk of Thrombosis in Patients with Triple-Positive Antiphospholipid Syndrome 6 ADVERSE REACTIONS 6.1 Clinical Trials Experience 6.2 Postmarketing Experience 7 DRUG INTERACTIONS 7.1 Reduction of Risk of Stroke and Systemic Embolism in Non- ...
Prophylaxis of DVT following hip or knee replacement …
packageinserts.bms.com7.1 Combined P-gp and Strong CYP3A4 Inhibitors 7.2 Combined P-gp and Strong CYP3A4 Inducers 7.3 Anticoagulants and Antiplatelet Agents 8 USE IN SPECIFIC POPULATIONS 8.1 Pregnancy 8.2 Lactation 8.3 Females and Males of Reproductive Potential 8.4 Pediatric Use 8.5 Geriatric Use 8.6 Renal Impairment 8.7 Hepatic Impairment 10 OVERDOSAGE 11 …
HIGHLIGHTS OF PRESCRIBING INFORMATION Use of …
www.rxabbvie.com7.1 Strong CYP3A4 Inhibitors 7.2 Strong CYP3A4 Inducers 8 USE IN SPECIFIC POPULATIONS 8.1 Pregnancy 8.2 Lactation 8.3 Females and Males of Reproductive Potential 8.4 Pediatric Use 8.5 Geriatric Use 8.6 Renal Impairment 8.7 Hepatic Impairment 11DESCRIPTION 12 CLINICAL PHARMACOLOGY 12.1 Mechanism of Action 12.2 …
Paxlovid Product Information
www.tga.gov.auHMG-CoA reductase inhibitors . simvastatin Nonsteroidal anti-inflammatory drugs (NSAIDs) piroxicam Opioid analgesic pethidine PDE5 inhibitor avanafil, sildenafil, vardenafil, tadalafil Sedative/hypnotics diazepam . PAXLOVID is contraindicated with drugs that are potent CYP3A inducers where significantly
Lynparza Full Prescribing Information
den8dhaj6zs0e.cloudfront.netCYP3A Inhibitors 2.5 Dosage Modifications for Renal Impairment 3 DOSAGE FORMS AND STRENGTHS. 4 CONTRAINDICATIONS. 5 WARNINGS AND PRECAUTIONS. 5.1 Myelodysplastic Syndrome/Acute Myeloid Leukemia 5.2 Pneumonitis 5.3 Embryo-Fetal Toxicity 5.4 Venous Thromboembolic Events 6 ADVERSE REACTIONS. 6.1 Clinical Trial Experience …